InvestorsHub Logo
Followers 0
Posts 3
Boards Moderated 0
Alias Born 08/06/2017

Re: fga post# 1181

Sunday, 08/06/2017 1:13:00 PM

Sunday, August 06, 2017 1:13:00 PM

Post# of 3011
True, cannot know. But here's the rub, the last news related to CC-31244 which gad a promising study and which seems to be a good candidate for more clinical trials. Last quarter they announced that they were looking for a partner for this on this compound and of course we haven't heard anything. Why? If this is Schinazi, the founder of Pharmasset who sold to Gilead gor $11bn, why is it that nobody is interested in partnering here? (at least as far as we know)

The only news is the appointment of the interim CFO as a permanent CFO and we see that Schinazi exercised some optioms to buy stock at just over 4 cents per share.

The stock continues to be in the doldrums with market excitement over the participants seemingly non existent.

Bit disconcerting. At least the 10Q is coming.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent COCP News